Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome

Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome

Show other versions (1)

Bibliographic Details
Main Authors:	Massimo Pancione, Lina Sabatino, Alessandra Fucci, Vincenzo Carafa, Angela Nebbioso, Nicola Forte, Antonio Febbraro, Domenico Parente, Concetta Ambrosino, Nicola Normanno, Lucia Altucci, Vittorio Colantuoni
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021485/?tool=EBI

Similar Items

Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
by: Massimo Pancione, et al.
Published: (2010-12-01)

Correction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome.
by: Massimo Pancione, et al.
Published: (2011-01-01)

PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis
by: Lina Sabatino, et al.
Published: (2012-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in the Esophageal, Gastric, and Colorectal Cancer
by: Alessandra Fucci, et al.
Published: (2012-01-01)

Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
by: Vincenzo Carafa, et al.
Published: (2019-01-01)

MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer
by: Tommaso Colangelo, et al.
Published: (2013-09-01)

Retraction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome.
by: PLOS ONE Editors
Published: (2019-01-01)

Epigenetic activation and silencing of the gene that encodes IFN-γ
by: Thomas Martin Aune, et al.
Published: (2013-05-01)

Sirtuins & disease: the road ahead
by: Vincenzo eCarafa, et al.
Published: (2012-01-01)

Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis
by: Massimo Pancione, et al.
Published: (2014-01-01)

Cancer epigenetics: Moving forward.
by: Angela Nebbioso, et al.
Published: (2018-06-01)

Gene Transactivation and Transrepression in MYC-Driven Cancers
by: Marika Scafuro, et al.
Published: (2021-03-01)

Epigenetic Silencing of the Protocadherin Family Member PCDH-γ-All in Astrocytomas
by: Anke Waha, et al.
Published: (2005-03-01)

Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
by: Mariarosaria Conte, et al.
Published: (2021-12-01)

Deregulation of Cell Death in Cancer: Recent Highlights
by: Vincenzo Carafa, et al.
Published: (2020-11-01)

Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling.
by: Stefano Maria Pagnotta, et al.
Published: (2013-01-01)

Combination treatments in in vitro and in vivo models between molecules reverting epigenetic gene silencing and DNA-interacting anticancer drugs
by: Sabatino, Maria Antonietta
Published: (2008)

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
by: Silvia Martina Ferrari, et al.
Published: (2015-01-01)

Nickel and Epigenetic Gene Silencing
by: Hong Sun, et al.
Published: (2013-10-01)

Epigenetic silencing in transgenic plants
by: Sarma eRajeev Kumar, et al.
Published: (2015-09-01)

SIRT1 Activation by Natural Phytochemicals: An Overview
by: Concetta Iside, et al.
Published: (2020-08-01)

The Role of Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) in Seizure and Neuronal Excitability
by: Fang-LiangChu, et al.
Published: (2016)

Peroxisome Proliferator-Activated Receptor γ (PPARγ)-Independent Antitumor Effect of Thiazolidinediones
by: Wei, Shuo
Published: (2009)

Effect of peroxisome proliferator-activated receptor γ on inflammatory markers
by: Majid Khazaei
Published: (2015-07-01)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
by: Huang-Jun Liu, et al.
Published: (2016-01-01)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
by: Su Zhang, et al.
Published: (2015-01-01)

Roles of Peroxisome Proliferator-activated Receptor-γ in Diabetic Heart
by: Ting-I Lee, et al.
Published: (2012)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
by: Kousei Ohshima, et al.
Published: (2012-01-01)

Durable CRISPR-Based Epigenetic Silencing
by: Muneaki Nakamura, et al.
Published: (2021-01-01)

Epigenetic Silencing of DKK3 in Medulloblastoma
by: André Oberthuer, et al.
Published: (2013-04-01)

Mechanisms of epigenetic gene silencing in tumourigenesis
by: Lynch, Catherine Anne
Published: (2005)

Nuclear organisation and the epigenetics of gene silencing
by: Bannister, Kirsty
Published: (2008)

The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer
by: Laura Della Torre, et al.
Published: (2021-02-01)

Establishment of the expression of human peroxisome activated receptor γ in Escherichia coli
by: Chen, Jyun-Ting, et al.
Published: (2017)

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches
by: M S Rasin
Published: (2013-09-01)

Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis
by: Jakub Żółkiewicz, et al.
Published: (2019-04-01)

Study of the polymorphism of peroxisome proliferator-activated receptor-γ in NAFLD patients
by: Fu-Chi, et al.
Published: (2008)

Role of peroxisome proliferator activated-receptor γ in lung epithelial cells
by: Patel, Kajal M.
Published: (2005)

Peroxisomal β-oxidation and Production of γ-decalactone by the Yeast Rhodotorula aurantiaca
by: Mohamed ALCHIHAB, et al.
Published: (2010-09-01)

Telomeric trans-silencing: an epigenetic repression combining RNA silencing and heterochromatin formation.
by: Thibaut Josse, et al.
Published: (2007-09-01)